Thrombotic thrombocytopenic purpura epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 38: | Line 38: | ||
*[Disease name] is a common/rare disease that tends to affect [patient population 1] and [patient population 2]. | *[Disease name] is a common/rare disease that tends to affect [patient population 1] and [patient population 2]. | ||
==References== | ==References== | ||
Revision as of 19:03, 26 September 2018
|
Xyz Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Thrombotic thrombocytopenic purpura epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Thrombotic thrombocytopenic purpura epidemiology and demographics |
|
FDA on Thrombotic thrombocytopenic purpura epidemiology and demographics |
|
CDC on Thrombotic thrombocytopenic purpura epidemiology and demographics |
|
Thrombotic thrombocytopenic purpura epidemiology and demographics in the news |
|
Blogs on Thrombotic thrombocytopenic purpura epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
Epidemiology and Demographics
Incidence
- The incidence of acuired TTP is about 0.3 per 100,000 adult per year [1]
- Data suggests the increased risk of TTP in black race and femal sex [2].
Prevalence
- The incidence/prevalence of [disease name] is approximately [number range] per 100,000 individuals worldwide.
- In [year], the incidence/prevalence of [disease name] was estimated to be [number range] cases per 100,000 individuals worldwide.
- The prevalence of [disease/malignancy] is estimated to be [number] cases annually.
Case-fatality rate/Mortality rate
- In [year], the incidence of [disease name] is approximately [number range] per 100,000 individuals with a case-fatality rate/mortality rate of [number range]%.
- The case-fatality rate/mortality rate of [disease name] is approximately [number range].
Age
- Patients of all age groups may develop [disease name].
- The incidence of [disease name] increases with age; the median age at diagnosis is [#] years.
- [Disease name] commonly affects individuals younger than/older than [number of years] years of age.
- [Chronic disease name] is usually first diagnosed among [age group].
- [Acute disease name] commonly affects [age group].
Race
- There is no racial predilection to [disease name].
- [Disease name] usually affects individuals of the [race 1] race. [Race 2] individuals are less likely to develop [disease name].
Gender
- [Disease name] affects men and women equally.
- [Gender 1] are more commonly affected by [disease name] than [gender 2]. The [gender 1] to [gender 2] ratio is approximately [number > 1] to 1.
Region
- The majority of [disease name] cases are reported in [geographical region].
- [Disease name] is a common/rare disease that tends to affect [patient population 1] and [patient population 2].
References
- ↑ Reese JA, Muthurajah DS, Kremer Hovinga JA, Vesely SK, Terrell DR, George JN (October 2013). "Children and adults with thrombotic thrombocytopenic purpura associated with severe, acquired Adamts13 deficiency: comparison of incidence, demographic and clinical features". Pediatr Blood Cancer. 60 (10): 1676–82. doi:10.1002/pbc.24612. PMID 23729372.
- ↑
Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.